Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy

Authors

Christopher P. Venner (ORCID: https://orcid.org/0000-0003-4701-4285)
Alina S. Gerrie (ORCID: https://orcid.org/0000-0003-4727-1425)
Pedro Farinha (ORCID: https://orcid.org/0000-0001-9364-9391)
Aixiang Jiang (ORCID: https://orcid.org/0000-0002-6153-7595)
Kerry J. Savage (ORCID: https://orcid.org/0000-0002-5835-9863)
Laurie H. Sehn (ORCID: https://orcid.org/0000-0003-1860-9765)
Diego R. Villa (ORCID: https://orcid.org/0000-0002-4625-3009)
David W. Scott (ORCID: https://orcid.org/0000-0003-4918-2610)
Anna Hayden (ORCID: https://orcid.org/0000-0001-9762-7261)
Jiayu Yang (ORCID: https://orcid.org/0009-0005-7102-3124)

Institutions

BC Cancer Agency (CA)
University of British Columbia (CA)
Spinal Cord Injury BC (CA)

Publication Details

Journal: Haematologica
Published: 2025-10-02
DOI: https://doi.org/10.3324/haematol.2025.288699
Primary Topic: CNS Lymphoma Diagnosis and Treatment
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Bristol-Myers Squibb
AstraZeneca
Teva Pharmaceutical Industries
Regeneron Pharmaceuticals
BeiGene
Seagen
Genentech

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy

Christopher P. Venner, Alina S. Gerrie, Pedro Farinha, Aixiang Jiang et al.

Oct 2, 2025

Haematologica

CNS Lymphoma Diagnosis and Treatment

article

Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy

Christopher P. Venner, Alina S. Gerrie, Pedro Farinha, Aixiang Jiang, Kerry J. Savage, Laurie H. Sehn, Diego R. Villa, David W. Scott, Anna Hayden, Jiayu Yang

October 2, 2025article en

Abstract

No abstract available for this paper.

HaematologicaVol. 111(3)

BC Cancer Agency (CA), University of British Columbia (CA), Spinal Cord Injury BC (CA)

Bristol-Myers Squibb, AstraZeneca, Teva Pharmaceutical Industries, Regeneron Pharmaceuticals, BeiGene, Seagen, Genentech

Openalex Percentile: Top 61%

CNS Lymphoma Diagnosis and Treatment

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy — Christopher P. Venner, Alina S. Gerrie, et al. · Haematologica (2025) | TGRS Research Map | TGRS